Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Potent preclinical activity of FLT3-directed chimeric antigen receptor T-cell immunotherapy against FLT3- mutant acute myeloid leukemia and KMT2A-rearranged acute lymphoblastic leukemia.
Niswander LM, Graff ZT, Chien CD, Chukinas JA, Meadows CA, Leach LC, Loftus JP, Kohler ME, Tasian SK, Fry TJ. Niswander LM, et al. Among authors: tasian sk. Haematologica. 2023 Feb 1;108(2):457-471. doi: 10.3324/haematol.2022.281456. Haematologica. 2023. PMID: 35950535 Free PMC article.
Targeting FLT3 Signaling in Childhood Acute Myeloid Leukemia.
Sexauer AN, Tasian SK. Sexauer AN, et al. Among authors: tasian sk. Front Pediatr. 2017 Nov 20;5:248. doi: 10.3389/fped.2017.00248. eCollection 2017. Front Pediatr. 2017. PMID: 29209600 Free PMC article. Review.
Opportunities for immunotherapy in childhood acute myeloid leukemia.
Lamble AJ, Tasian SK. Lamble AJ, et al. Among authors: tasian sk. Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):218-225. doi: 10.1182/hematology.2019000357. Hematology Am Soc Hematol Educ Program. 2019. PMID: 31808843 Free PMC article. Review.
99 results